We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

There are no directors' trades from BetaShares NASDAQ 100 ETF (NDQ). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities. What is the ...

Steris (STE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a ...

Maze Therapeutics begins Phase 2 trial for kidney disease drug By Investing.com - Feb 07, 2025 SOUTH SAN FRANCISCO – Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical ...

Nvidia (NASDAQ: NVDA) stock posted significant gains in Wednesday's trading following bullish artificial intelligence (AI) news. The company's share price closed out the day up 4.4% amid the ...

Tech stocks led the market on Wednesday as Netflix (NFLX) stock surged to a record, while President Donald Trump's boost to AI demand hopes outweighed fresh tariff worries. Meanwhile, the Dow ...

Shares of Grail, a medical technology company, jumped 20% Wednesday to lead Nasdaq 100 gainers. Grail spun off from Illumina last year, and is developing a number of early detection cancer ...

The Nasdaq 100 Index has nearly doubled since the start of 2023, adding $14 trillion in value in the process. Evercore ISI’s Rich Ross is prepared for that rally to continue, shrugging off fears ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: JPMorgan Chase & Co. JPM: This financial services giant has seen the Zacks Consensus Estimate for its current year earnings ...